Logo image of SALM.OL

SALMAR ASA (SALM.OL) Stock Fundamental Analysis

Europe - OSL:SALM - NO0010310956 - Common Stock

551 NOK
+2.5 (+0.46%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

4

SALM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 59 industry peers in the Food Products industry. There are concerns on the financial health of SALM while its profitability can be described as average. SALM is valied quite expensively at the moment, while it does show a decent growth rate. Finally SALM also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

SALM had positive earnings in the past year.
SALM had a positive operating cash flow in the past year.
In the past 5 years SALM has always been profitable.
Each year in the past 5 years SALM had a positive operating cash flow.
SALM.OL Yearly Net Income VS EBIT VS OCF VS FCFSALM.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

1.2 Ratios

SALM's Return On Assets of 2.08% is in line compared to the rest of the industry. SALM outperforms 40.68% of its industry peers.
SALM has a Return On Equity of 7.34%. This is comparable to the rest of the industry: SALM outperforms 50.85% of its industry peers.
With a Return On Invested Capital value of 3.33%, SALM is not doing good in the industry: 66.10% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for SALM is in line with the industry average of 7.03%.
Industry RankSector Rank
ROA 2.08%
ROE 7.34%
ROIC 3.33%
ROA(3y)5.59%
ROA(5y)7.01%
ROE(3y)16.59%
ROE(5y)17.93%
ROIC(3y)7.18%
ROIC(5y)7.81%
SALM.OL Yearly ROA, ROE, ROICSALM.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With a decent Profit Margin value of 4.57%, SALM is doing good in the industry, outperforming 61.02% of the companies in the same industry.
In the last couple of years the Profit Margin of SALM has declined.
SALM's Operating Margin of 10.66% is fine compared to the rest of the industry. SALM outperforms 69.49% of its industry peers.
SALM's Operating Margin has declined in the last couple of years.
SALM's Gross Margin of 49.66% is fine compared to the rest of the industry. SALM outperforms 71.19% of its industry peers.
In the last couple of years the Gross Margin of SALM has remained more or less at the same level.
Industry RankSector Rank
OM 10.66%
PM (TTM) 4.57%
GM 49.66%
OM growth 3Y-4%
OM growth 5Y-3.92%
PM growth 3Y-13.56%
PM growth 5Y-11.19%
GM growth 3Y0.57%
GM growth 5Y-0.26%
SALM.OL Yearly Profit, Operating, Gross MarginsSALM.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SALM is destroying value.
The number of shares outstanding for SALM remains at a similar level compared to 1 year ago.
Compared to 5 years ago, SALM has more shares outstanding
SALM has a worse debt/assets ratio than last year.
SALM.OL Yearly Shares OutstandingSALM.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SALM.OL Yearly Total Debt VS Total AssetsSALM.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

SALM has an Altman-Z score of 2.02. This is not the best score and indicates that SALM is in the grey zone with still only limited risk for bankruptcy at the moment.
SALM's Altman-Z score of 2.02 is in line compared to the rest of the industry. SALM outperforms 47.46% of its industry peers.
A Debt/Equity ratio of 1.26 is on the high side and indicates that SALM has dependencies on debt financing.
The Debt to Equity ratio of SALM (1.26) is worse than 79.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Altman-Z 2.02
ROIC/WACC0.44
WACC7.62%
SALM.OL Yearly LT Debt VS Equity VS FCFSALM.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

SALM has a Current Ratio of 1.75. This is a normal value and indicates that SALM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SALM (1.75) is better than 69.49% of its industry peers.
A Quick Ratio of 0.27 indicates that SALM may have some problems paying its short term obligations.
SALM has a worse Quick ratio (0.27) than 94.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 0.27
SALM.OL Yearly Current Assets VS Current LiabilitesSALM.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

SALM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.06%.
Measured over the past years, SALM shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.01% on average per year.
Looking at the last year, SALM shows a decrease in Revenue. The Revenue has decreased by -9.03% in the last year.
SALM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.65% yearly.
EPS 1Y (TTM)-38.06%
EPS 3Y7.44%
EPS 5Y-0.01%
EPS Q2Q%-69.71%
Revenue 1Y (TTM)-9.03%
Revenue growth 3Y20.66%
Revenue growth 5Y16.65%
Sales Q2Q%5.77%

3.2 Future

The Earnings Per Share is expected to grow by 22.87% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.39% on average over the next years. This is quite good.
EPS Next Y-20.82%
EPS Next 2Y25.77%
EPS Next 3Y22.87%
EPS Next 5YN/A
Revenue Next Year11.59%
Revenue Next 2Y13.27%
Revenue Next 3Y11.59%
Revenue Next 5Y11.39%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SALM.OL Yearly Revenue VS EstimatesSALM.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B 40B 50B
SALM.OL Yearly EPS VS EstimatesSALM.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30 40

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 38.24, which means the current valuation is very expensive for SALM.
SALM's Price/Earnings ratio is a bit more expensive when compared to the industry. SALM is more expensive than 64.41% of the companies in the same industry.
SALM is valuated rather expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 15.61, SALM is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SALM is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of SALM to the average of the S&P500 Index (22.73), we can say SALM is valued slightly cheaper.
Industry RankSector Rank
PE 38.24
Fwd PE 15.61
SALM.OL Price Earnings VS Forward Price EarningsSALM.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SALM is valued a bit more expensive than the industry average as 77.97% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.01
SALM.OL Per share dataSALM.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

SALM's earnings are expected to grow with 22.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.77%
EPS Next 3Y22.87%

9

5. Dividend

5.1 Amount

SALM has a Yearly Dividend Yield of 4.28%, which is a nice return.
SALM's Dividend Yield is rather good when compared to the industry average which is at 3.25. SALM pays more dividend than 81.36% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, SALM pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.28%

5.2 History

On average, the dividend of SALM grows each year by 8.89%, which is quite nice.
Dividend Growth(5Y)8.89%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

7.41% of the earnings are spent on dividend by SALM. This is a low number and sustainable payout ratio.
The dividend of SALM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP7.41%
EPS Next 2Y25.77%
EPS Next 3Y22.87%
SALM.OL Yearly Income VS Free CF VS DividendSALM.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
SALM.OL Dividend Payout.SALM.OL Dividend Payout, showing the Payout Ratio.SALM.OL Dividend Payout.PayoutRetained Earnings

SALMAR ASA

OSL:SALM (9/12/2025, 7:00:00 PM)

551

+2.5 (+0.46%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-21 2025-08-21/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners74.57%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap74.60B
Analysts74.44
Price Target561.71 (1.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.28%
Yearly Dividend35.51
Dividend Growth(5Y)8.89%
DP7.41%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)29.34%
Min EPS beat(2)-46.06%
Max EPS beat(2)104.75%
EPS beat(4)2
Avg EPS beat(4)12.2%
Min EPS beat(4)-46.06%
Max EPS beat(4)104.75%
EPS beat(8)2
Avg EPS beat(8)-3.03%
EPS beat(12)3
Avg EPS beat(12)-15.4%
EPS beat(16)3
Avg EPS beat(16)-19.18%
Revenue beat(2)2
Avg Revenue beat(2)0.51%
Min Revenue beat(2)0.15%
Max Revenue beat(2)0.87%
Revenue beat(4)2
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-4.35%
Max Revenue beat(4)0.87%
Revenue beat(8)4
Avg Revenue beat(8)-1.28%
Revenue beat(12)6
Avg Revenue beat(12)-0.13%
Revenue beat(16)9
Avg Revenue beat(16)0.69%
PT rev (1m)2.46%
PT rev (3m)0%
EPS NQ rev (1m)-37.55%
EPS NQ rev (3m)-30.44%
EPS NY rev (1m)-49.29%
EPS NY rev (3m)-49.29%
Revenue NQ rev (1m)-9.27%
Revenue NQ rev (3m)-1.47%
Revenue NY rev (1m)-2.77%
Revenue NY rev (3m)-5.62%
Valuation
Industry RankSector Rank
PE 38.24
Fwd PE 15.61
P/S 2.94
P/FCF N/A
P/OCF 47.31
P/B 4.72
P/tB N/A
EV/EBITDA 21.01
EPS(TTM)14.41
EY2.62%
EPS(NY)35.29
Fwd EY6.4%
FCF(TTM)-7.21
FCFYN/A
OCF(TTM)11.65
OCFY2.11%
SpS187.62
BVpS116.74
TBVpS-35.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.08%
ROE 7.34%
ROCE 5.96%
ROIC 3.33%
ROICexc 3.36%
ROICexgc 6.23%
OM 10.66%
PM (TTM) 4.57%
GM 49.66%
FCFM N/A
ROA(3y)5.59%
ROA(5y)7.01%
ROE(3y)16.59%
ROE(5y)17.93%
ROIC(3y)7.18%
ROIC(5y)7.81%
ROICexc(3y)7.39%
ROICexc(5y)8.02%
ROICexgc(3y)13.13%
ROICexgc(5y)13.77%
ROCE(3y)12.87%
ROCE(5y)13.99%
ROICexcg growth 3Y-3.4%
ROICexcg growth 5Y-6.43%
ROICexc growth 3Y-7.07%
ROICexc growth 5Y-10.05%
OM growth 3Y-4%
OM growth 5Y-3.92%
PM growth 3Y-13.56%
PM growth 5Y-11.19%
GM growth 3Y0.57%
GM growth 5Y-0.26%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Debt/EBITDA 4.37
Cap/Depr 137.11%
Cap/Sales 10.05%
Interest Coverage 1.98
Cash Conversion 34.52%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 0.27
Altman-Z 2.02
F-Score3
WACC7.62%
ROIC/WACC0.44
Cap/Depr(3y)181.78%
Cap/Depr(5y)256.7%
Cap/Sales(3y)10.1%
Cap/Sales(5y)14.83%
Profit Quality(3y)125.18%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.06%
EPS 3Y7.44%
EPS 5Y-0.01%
EPS Q2Q%-69.71%
EPS Next Y-20.82%
EPS Next 2Y25.77%
EPS Next 3Y22.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.03%
Revenue growth 3Y20.66%
Revenue growth 5Y16.65%
Sales Q2Q%5.77%
Revenue Next Year11.59%
Revenue Next 2Y13.27%
Revenue Next 3Y11.59%
Revenue Next 5Y11.39%
EBIT growth 1Y-59.9%
EBIT growth 3Y15.83%
EBIT growth 5Y12.08%
EBIT Next Year48.46%
EBIT Next 3Y31.27%
EBIT Next 5YN/A
FCF growth 1Y-120.62%
FCF growth 3Y59.94%
FCF growth 5Y10.72%
OCF growth 1Y-73.83%
OCF growth 3Y22.76%
OCF growth 5Y12.18%